| Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn's disease: a prospective, multicentre, cohort study NA Kennedy, GA Heap, HD Green, B Hamilton, C Bewshea, GJ Walker, ... The lancet Gastroenterology & hepatology 4 (5), 341-353, 2019 | 560 | 2019 |
| Infliximab is associated with attenuated immunogenicity to BNT162b2 and ChAdOx1 nCoV-19 SARS-CoV-2 vaccines in patients with IBD NA Kennedy, S Lin, JR Goodhand, N Chanchlani, B Hamilton, ... Gut 70 (10), 1884-1893, 2021 | 257 | 2021 |
| Tolerability and compliance with risedronate in clinical practice B Hamilton, K McCoy, H Taggart Osteoporosis International 14, 259-262, 2003 | 208 | 2003 |
| Humeral shaft fractures: results of operative and non-operative treatment E Westrick, B Hamilton, P Toogood, B Henley, R Firoozabadi International orthopaedics 41, 385-395, 2017 | 85 | 2017 |
| Global urban environmental change drives adaptation in white clover JS Santangelo, RW Ness, B Cohan, CR Fitzpatrick, SG Innes, S Koch, ... Science 375 (6586), 1275-1281, 2022 | 73 | 2022 |
| Adalimumab and infliximab impair SARS-CoV-2 antibody responses: results from a therapeutic drug monitoring study in 11 422 biologic-treated patients N Chanchlani, S Lin, D Chee, B Hamilton, R Nice, Z Arkir, C Bewshea, ... Journal of Crohn's and Colitis 16 (3), 389-397, 2022 | 48 | 2022 |
| Risk factors for conversion to total hip arthroplasty after acetabular fractures involving the posterior wall R Firoozabadi, B Hamilton, P Toogood, D Shearer Journal of orthopaedic trauma 32 (12), 607-611, 2018 | 48 | 2018 |
| Contributors to the CLARITY IBD study. Infliximab is associated with attenuated immunogenicity to BNT162b2 and ChAdOx1 nCoV-19 SARS-CoV-2 vaccines in patients with IBD NA Kennedy, S Lin, JR Goodhand, N Chanchlani, B Hamilton, ... Gut 70 (10), 1884-1893, 2021 | 47 | 2021 |
| Genome-wide association study of microscopic colitis in the UK Biobank confirms immune-related pathogenesis HD Green, RN Beaumont, A Thomas, B Hamilton, AR Wood, S Sharp, ... Journal of Crohn's and Colitis 13 (12), 1578-1582, 2019 | 37 | 2019 |
| Determining stability in posterior wall acetabular fractures R Firoozabadi, C Spitler, C Schlepp, B Hamilton, J Agel, P Tornetta Journal of orthopaedic trauma 29 (10), 465-469, 2015 | 34 | 2015 |
| Incidence and prevalence of inflammatory bowel disease in Devon, UK B Hamilton, H Green, N Heerasing, P Hendy, L Moore, N Chanchlani, ... Frontline Gastroenterology 12 (6), 461-470, 2021 | 24 | 2021 |
| Genetic evidence that higher central adiposity causes gastro-oesophageal reflux disease: a Mendelian randomization study HD Green, RN Beaumont, AR Wood, B Hamilton, SE Jones, ... International journal of epidemiology 49 (4), 1270-1281, 2020 | 24 | 2020 |
| Root‐cause analyses of missed opportunities for the diagnosis of colorectal cancer in patients with inflammatory bowel disease C Gordon, D Chee, B Hamilton, NM Heerasing, P Hendy, N Chanchlani, ... Alimentary Pharmacology & Therapeutics 53 (2), 291-301, 2021 | 20 | 2021 |
| Neurologic injury in operatively treated acetabular fractures Y Bogdan, P Tornetta III, C Jones, AK Gilde, E Schemitsch, M Vicente, ... Journal of Orthopaedic Trauma 29 (10), 475-478, 2015 | 20 | 2015 |
| Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn’s disease: a prospective, multicentre, cohort study. Lancet Gastroenterol Hepatol … NA Kennedy, GA Heap, HD Green, B Hamilton, C Bewshea, GJ Walker, ... S2468-1253 (19), 30012-3, 2021 | 18 | 2021 |
| UK Inflammatory Bowel Disease Pharmacogenetics Study Group Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn’s disease: a … NA Kennedy, GA Heap, HD Green, B Hamilton, C Bewshea, GJ Walker Lancet Gastroenterol Hepatol 4 (5), 341, 2019 | 18 | 2019 |
| Determination of iso-alpha-, alpha-, and beta-acids in hop extracts and isomerized hop extracts by high-performance liquid chromatography J Raumschuh, R Ackermann, R Burkhardt, C Gant, B Hamilton, ... J. Am. Soc. Brew. Chem 57 (4), 162-165, 1999 | 17 | 1999 |
| Patient-led remote intracapillary pharmacoKinetic sampling (fingerPRICKS) for therapeutic drug monitoring in patients with inflammatory bowel disease D Chee, R Nice, B Hamilton, E Jones, S Hawkins, C Redstone, V Cairnes, ... Journal of Crohn's and Colitis 16 (2), 190-198, 2022 | 13 | 2022 |
| Implications for sequencing of biologic therapy and choice of second anti‐TNF in patients with inflammatory bowel disease: results from the IMmunogenicity to Second Anti‐TNF … N Chanchlani, S Lin, MK Auth, CL Lee, H Robbins, S Looi, SV Murugesan, ... Alimentary Pharmacology & Therapeutics 56 (8), 1250-1263, 2022 | 10 | 2022 |
| Clinical features and genetic risk of demyelination following anti-TNF treatment S Lin, HD Green, P Hendy, NM Heerasing, N Chanchlani, B Hamilton, ... Journal of Crohn's and Colitis 14 (12), 1653-1661, 2020 | 9 | 2020 |
